Jiangxi Haiwen Biotechnology Co., Ltd won the bid to acquire Anhui Redpont Biotechnology Co., Ltd. from Nanjing Red Sun Co.,Ltd. (SZSE:000525) for approximately RMB 210 million on March 26, 2022.

Jiangxi Haiwen Biotechnology Co., Ltd completed the acquisition of Anhui Redpont Biotechnology Co., Ltd. from Nanjing Red Sun Co.,Ltd. (SZSE:000525) on April 15, 2022.